Cat. No. 2793
Chemical Name: 3,7-Dihydro-1,3,7-trimethyl-1H-puri
Biological ActivityCentral nervous system stimulant. Antagonist at A1 and A2A adenosine receptors and inhibitor of cyclic nucleotide phosphodiesterases. Mobilizes calcium from intracellular stores and inhibits benzodiazepine binding to GABA receptors.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Chen et al (2008) Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J.Neuroinflammation 5 12. PMID: 18387175.
Fisone et al (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cell.Mol.Life Sci. 61 857. PMID: 15095008.
Nehlig et al (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res.Brain Res.Rev. 17 139. PMID: 1356551.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Caffeine include:
Okita et al (2015) Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells. PLoS One 10 e0139809. PMID: 26439264.
Seto et al (2013) Acute simvastatin inhibits K ATP channels of porcine coronary artery myocytes. J Cell Sci 8 e66404. PMID: 23799098.
Do you know of a great paper that uses Caffeine from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Caffeine, supplier, A1, A2B, antagonists, CNS, stimulant, cyclic, nucleotide, PDE, inhibitors, inhibits, non-selective, adenosines, receptors, phosphodiesterases, ryanodine, receptors, Tocris Bioscience, Non-selective Adenosine Antagonist products
Find multiple products by catalog number
New Products in this Area
High affinity adenosine A1 receptor antagonistISAM 140
High affinity A2B receptor antagonist
April 22 - 26, 2017
Chicago, IL, USA